Lv2
134 积分 2022-09-02 加入
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
1天前
已完结
[Expert consensus on diagnosis and treatment of malignant pleural effusion caused by lung cancer]
1个月前
已完结
[Chinese expert consensus on clinical testing standards of PD-L1 expression for non-small cell lung cancer (2023 version)]
1个月前
已完结
Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study
2个月前
已完结
Interstitial Lung Disease
3个月前
已完结
Interstitial lung diseases
3个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
4个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
4个月前
已完结
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
5个月前
已完结
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
5个月前
已完结
Silver nanoparticles/carbon dots nanocomposite with potent antibiofilm and long-term antimicrobial activity doped into chitosan/polyvinyl alcohol film for food preservation
4个月前
已采纳
The polysaccharide from purple sweet potato (Ipomoea batatas (L.) Lam) alleviates lipopolysaccharide-induced acute lung injury in mice via the VIP/cAMP/PKA/AQPs signaling pathway
4个月前
已采纳
Fish skin dressing for wound regeneration: A bioactive component review of omega-3 PUFAs, collagen and ECM
4个月前
已采纳
Epidemiological typing of Flavimonas oryzihabitans by PCR and pulsed-field gel electrophoresis
4个月前
已采纳
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1年前
已采纳
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1年前
已采纳
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1年前
已采纳
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1年前
已采纳
皖公网安备34019202002308
